MUSK and myasthenia gravis: Antibodies to the muscle-specific receptor tyrosine kinase (anti-MuSK) have been reported as a subgroup of MG with more localized clinical symptoms and a worse response to therapy than individuals who have antibodies to the anti-AChR [29].